$AURA
Aura Biosciences, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Boston, MA
AURA chart
What traders are saying about $AURA
Latest postsAura Biosciences, Inc. news
- Aura Biosciences CEO to speak at Morgan Stanley healthcare conference
scanx.trade ·
- Aura Biosciences Share News - Latest Updates, Live News & More
scanx.trade ·
- Aura Biosciences, Inc. Estimates – NASDAQ:AURA
TradingView ·
- Precision Trading with Aura Biosciences Inc. (AURA) Risk Zones
Stock Traders Daily ·
- Is Aura Investments (TASE:AURA) Fully Valued As Mixed Earnings And A New Dividend Stir Interest?
Yahoo Finance ·
- Aura Biosciences to Participate in Upcoming Investor Conference
Yahoo Finance ·
- Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Aura Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Yahoo Finance ·
- Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
Yahoo Finance ·
- Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma
Yahoo Finance ·
- Aura Biosciences Gears Up for Bel-Sar Filing as Pivotal Eye Cancer Trial Advances
marketbeat.com ·
- Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data
marketbeat.com ·
Aura Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$106.2M | -$86.9M | -$76.4M | -$58.8M |
| Diluted EPS | $-1.76 | $-1.75 | $-1.93 | $-1.96 |
| Total assets (year end) | $169.4M | $182.5M | $255.1M | $223.9M |
| Cash and equivalents (year end) | $59.5M | $31.7M | $41.1M | $121.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aura Biosciences, Inc.
- Ticker
- AURA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1501796
Frequently asked questions
What exchange is Aura Biosciences, Inc. listed on?
Aura Biosciences, Inc. trades on the Nasdaq under the ticker symbol AURA.
What industry is Aura Biosciences, Inc. in?
Aura Biosciences, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Aura Biosciences, Inc. headquartered?
Aura Biosciences, Inc.'s business address on file with the SEC is in Boston, MA.
When does Aura Biosciences, Inc.'s fiscal year end?
Aura Biosciences, Inc.'s fiscal year ends on December 31.